Canopy Growth (WEED) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Aug, 2026Executive summary
Annual General and Special Meeting scheduled for September 25, 2026, with voting open until September 23, 2026.
Shareholders are encouraged to review proxy materials online and vote electronically or by mail.
Notice-and-access method used for proxy material delivery, reducing paper distribution.
Voting matters and shareholder proposals
Election of five directors: David Lazzarato, Theresa Yanofsky, Luc Mongeau, Shan Atkins, and Joseph Bayern.
Appointment of MNP LLP as auditor for fiscal year ending March 31, 2027, with board authorized to set remuneration.
Special resolution to consolidate shares at a ratio of 1-for-5 to 1-for-15, with the exact ratio determined by the board before September 25, 2027.
Ordinary resolution to ratify By-Law No. 2, establishing advance notice requirements for director nominations.
Approval of all unallocated entitlements under the Omnibus Incentive Plan.
Advisory vote on executive compensation and on the frequency of future say-on-pay votes (recommended: annual).
Board of directors and corporate governance
Board nominees include a mix of experienced professionals from various backgrounds.
By-Law No. 2 introduces advance notice and procedural requirements for shareholder director nominations.
Latest events from Canopy Growth
- Strategic transformation and premium positioning drive growth and margin expansion in key cannabis markets.WEED
Canaccord Genuity's 46th Annual Growth Conference - Shareholders to vote on key governance, compensation, and capital structure proposals at the 2026 AGM.WEED
Proxy filing - Net revenue rose 13% and adjusted EBITDA loss narrowed 59%, with improved margins and market share.WEED
Q1 2027 - Shareholders will vote on key governance, compensation, and capital structure proposals at the 2026 meeting.WEED
Proxy filing - FY2026 net revenue rose 6% to $284.6M, driven by Canadian growth and MTL Cannabis acquisition.WEED
Investor presentation - All proposals passed, with management highlighting U.S. regulatory opportunities and product innovation.WEED
AGM 2024 - Revenue up 6%, margins improved, and cash position strengthened, with strong growth in Canada and Europe.WEED
Q4 2026 - Acquisition creates Canada's top medical cannabis provider and accelerates profitability.WEED
M&A presentation - Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold.WEED
Q3 2026